ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,848
Screening encounters
3,213
Diagnostic referrals
620
Outstanding pathways
240

Screening pathway

  1. Screening3,213Encounters
  2. Positive finding1,096Documented findings
  3. Referral620Diagnostic referrals
  4. Follow-up725Diagnostic visits
  5. Outcome380Resolved pathways

Stage totals use different units. Pending pathways: 240. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2909 · EXP-2909Synthetic · Site D

Full participant history through 2026-05-26, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA positive
  4. · Diagnostic referral · EXP-2909-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-01-13
  11. · Follow-up disposition · Resolved · EXP-2909-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2848 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2913 · Expanded synthetic participant 2913Site B — Peri-Urban Access Programme
EXP-2914 · Expanded synthetic participant 2914Site A — Urban Referral Hub
EXP-2915 · Expanded synthetic participant 2915Site C — Rural Outreach Programme
EXP-2916 · Expanded synthetic participant 2916Site C — Rural Outreach Programme
EXP-2918 · Expanded synthetic participant 2918Site A — Urban Referral Hub
EXP-2919 · Expanded synthetic participant 2919Site A — Urban Referral Hub
EXP-2922 · Expanded synthetic participant 2922Site C — Rural Outreach Programme
EXP-2923 · Expanded synthetic participant 2923Site A — Urban Referral Hub
EXP-2925 · Expanded synthetic participant 2925Site A — Urban Referral Hub
EXP-2926 · Expanded synthetic participant 2926Site C — Rural Outreach Programme
EXP-2930 · Expanded synthetic participant 2930Site B — Peri-Urban Access Programme
EXP-2935 · Expanded synthetic participant 2935Site A — Urban Referral Hub
EXP-2936 · Expanded synthetic participant 2936Site C — Rural Outreach Programme
EXP-2938 · Expanded synthetic participant 2938Site C — Rural Outreach Programme
EXP-2939 · Expanded synthetic participant 2939Site A — Urban Referral Hub
EXP-2943 · Expanded synthetic participant 2943Site B — Peri-Urban Access Programme
EXP-2944 · Expanded synthetic participant 2944Site B — Peri-Urban Access Programme
EXP-2947 · Expanded synthetic participant 2947Site E — Resource-Constrained Navigation Programme
EXP-2948 · Expanded synthetic participant 2948Site A — Urban Referral Hub
EXP-2949 · Expanded synthetic participant 2949Site B — Peri-Urban Access Programme
EXP-2950 · Expanded synthetic participant 2950Site D — Community Engagement Programme
EXP-2953 · Expanded synthetic participant 2953Site E — Resource-Constrained Navigation Programme
EXP-2955 · Expanded synthetic participant 2955Site B — Peri-Urban Access Programme
EXP-2956 · Expanded synthetic participant 2956Site C — Rural Outreach Programme
EXP-2959 · Expanded synthetic participant 2959Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1301
HPV DNA
1440
Cytology
472

Navigation activity

Barrier documented
535
Contact attempt
917
Navigation intervention
231
Diagnostic booking
773
Diagnostic visit
725

Documented barriers

Contact difficulty
177
Transport difficulty
165
Appointment coordination
193

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.